In the media STAT Opinion: Businesses across the vaccine supply chain must work together to make Covid-19 vaccines Andrey Zarur, CEO of GreenLight Biosciences, wrote for STAT about the Covid-19 vaccine supply chain. Continue reading → 15 January 2021 By Patrick 0 Comments
In the media Financial Times: Get vaccine new variant ready GreenLight Biosciences spoke to the Financial Times about making sure that any vaccine is new variant ready for Covid-19. Continue reading → 13 January 2021 By Patrick 0 Comments
In the media Financial Times: Vaccine makers race to fix vaccine supply issues GreenLight Biosciences spoke to the Financial Times about the vaccine supply issues for the Covid-19 vaccine Continue reading → 12 January 2021 By Patrick 0 Comments
In the media Mail Online: Vaccine roll out issues GreenLight Biosciences spoke to Mail Online about the vaccine supply issues in rolling out the Covid-19 vaccine Continue reading → 12 January 2021 By Patrick 0 Comments
In the media Technology Review: What are the Pfizer covid-19 vaccine ingredients? GreenLight Biosciences spoke to Technology Review about the vaccine ingredients for Pfizer’s Covid-19 vaccine, including messenger RNA. Continue reading → 9 December 2020 By Patrick 0 Comments
In the media Financial Times: Vaccine manufacturing delays leave UK with fewer vaccines than hoped GreenLight CEO, Andrey Zarur, spoke to the Financial Times about the Covid-19 vaccine manufacturing delays, with the hold up leaving the UK with fewer vaccines dosages than it had hoped. Continue reading → 4 December 2020 By Patrick 0 Comments
In the media Investors Business Daily: Vaccine manufacturing challenge GreenLight CEO, Andrey Zarur, spoke to Investor’s Business Daily about the Covid-19 vaccine manufacturing challenge, with billions around the world in need. Continue reading → 3 December 2020 By Patrick 0 Comments
In the media BioSpace: Harnessing Nature for Faster mRNA Vaccine Manufacturing With manufacturing capacity in the news following the announcement of successful Covid-19 vaccine trials, Greenlight Biosciences CEO Andrey Zarur explains to Biospace the potential of the messenger RNA vaccine Continue reading → 25 November 2020 By Patrick 0 Comments
In the media Wired: Manufacturing enough Covid-19 vaccine is a logistical nightmare GreenLight CEO Andrey Zarur tells Wired about the difficulties in vaccine manufacturin Continue reading → 20 November 2020 By Patrick 0 Comments